INK4a is implicated in replicative senescence, cell immortalization, and tumor generation. However, the mechanism regulating its overexpression in senescent cells is unknown. We used the enhanced green fluorescent protein reporter system to scan regulatory elements in the upstream region of p16 
Cellular senescence consists of the loss of proliferative potential produced by the accumulation of cell doublings (1) . A number of regulatory proteins have been proposed to transduce senescence-inducing signals or mediate entrance of the cell into the senescence stage. Prominent among these is the p16 INK4a tumor suppressor protein (2, 3) . p16
INK4a is a negative regulator of the cell cycle. It inhibits CDK4/CDK6-mediated phosphorylation of retinoblastoma gene product (pRB) and causes cell cycle arrest in G 1 phase (4). The p16
INK4a gene is progressively up-regulated as fibroblasts undergo increasing numbers of cell divisions and approach senescence (2, 6 -8) . Reexpression of the gene by promoter demethylation with 5-azacytidine (9) or transfection into normal young human diploid fibroblast cells to induce overexpression of p16 (10) causes a senescent-like changes including suppression of growth rate with cell cycle arrest at G 1 phase, increase of cell volume, and expression of a neutral senescence-associated ␤-galactosidase. Neilsen et al. (11) analyzed the immunohistochemical localization of p16 INK4a in all human organs and demonstrated that cellular p16
INK4a expression is highly selective. In adults, p16
INK4a is widely expressed in many tissues such as proliferative endometrium, breast ductal epithelium, squamous and tubal metaplastic epithelium of the uterine cervix, esophageal squamous epithelium, and salivary glands among others. In infants, p16
INK4a staining was limited to thymic Hassall's corpuscles, occasional thymic lymphocytes, and only rare pancreatic epithelial cells. Therefore, restriction of p16
INK4a expression in infants to the thymus, the only organ committed to early senescence and increased expression of p16
INK4a in adult tissues, may reflect a role of p16
INK4a in normal organ senescence. Consistent with the role of p16
INK4a in senescence, inactivation of the p16
INK4a /Rb pathway results in life span extension or immortalization. Mouse fibroblasts that have bypassed senescence have often lost expression of p16
INK4a (12) . In certain human cell types, such as human keratinocytes or mammary epithelial cells, in which telomerase expression alone is insufficient to bypass senescence, the additional inactivation of p16 INK4a by genetic or epigenetic mechanisms is required to bypass senescence and render the cells immortal (13, 14) . Similarly, viral oncoproteins such as SV40 large T antigen, adenoviral E1a protein, or herpesvirus E7 protein inactivate the growth-suppressive functions of Rb and facilitate immortalization (15, 16) .
Despite the widespread alterations of p16 INK4a in senescence, immortalization and tumorgenesis, little is known about the transcription regulatory mechanism of this gene. Therefore, we have initiated a search for specific transcription regulatory elements whose function may contribute to up-regulation of p16
INK4a in senescent fibroblasts. In this paper, we describe a novel negative transcription regulatory element, the INK4a transcription silence element (ITSE), 1 within sequence Ϫ491 to Ϫ485 bp of the p16
INK4a promoter. A 24-kDa protein that was highly expressed in young cells may inhibit the expression of p16
INK4a by interacting with ITSE. A GC-abundant element located in the region from Ϫ466 to Ϫ451 bp was also involved with high expression of p16
INK4a in senescent fibroblasts.
MATERIALS AND METHODS
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logical Products (Beijing, China). The current expected life span is ϳ70 population doublings (PD). 2BS cells were considered to be young at PD 30 or below and to be fully senescent at PD 55 or above.
RetroPack TM PT-67 cell line (CLONTECH) is a retrovirus packaging cell line. In conjunction with a retroviral vector, it allows production of infectious, replication-incompetent retrovirus that can be used to introduce a gene of interest into a wide variety of mammalian cell types in vitro or in vivo.
2BS and PT-67 cells were cultured in Dulbecco's modified Eagle's medium (Life Technologies, Inc.), which contained 10% fetal bovine serum (Life Technologies), 100 units/ml penicillin, and 100 g/ml streptomycin.
Plasmid Construction-Self-inactivating retrovirus vector pSIR-EGFP was constructed in pSIR (CLONTECH) by inserting an EGFPSV40poly(A) fragment derived from pEGFP-1 (CLONTECH) into EcoRI and BamHI positions. A p16
INK4a promoter fragment containing nucleotides Ϫ1 to Ϫ3017 relative to the ATG in pGL2-Basic vector was generously provided by Dr. Gorden Peters (Imperial Cancer Research Fund Laboratories, London, UK). A series of 5Ј truncations were generated with different endonucleases listed in Fig. 1 . Various fragments were isolated from restriction digests and were ligated between the XhoI and HindIII sites in pSIR-EGFP.
Retrovirus Packaging and Transduction Assay-Transfections of plasmids containing p16 promoter 5Ј-deletions into PT67 retroviral packaging cells were performed with Lipofectin TM (Life Technologies). Drug selection (500 g of G418/ml) was started 2 days after transfection and continued for 10 -14 days. Virus-producing cell clones were mixed and cultured to generate retroviral supernatants in Dulbecco's modified Eagle's medium, which were gathered by passing through a 0.45-m pore size filter and stored at Ϫ80°C until use.
Young 2BS cells (PDL 22) plated 1 day earlier at ϳ10 5 cells/9-cm 2 well were transduced by refeeding them for 10 -12 h with retroviral supernatant plus polybrene (4 g/ml; Sigma). The treated cells were subcultured the next day into 50-cm 2 flasks (Costar). Drug selection (200 g of G418/ml) was started 2 days after transfection and continued for 14 days. Cell clones were mixed and cultured to their finite life span under the selection with 50 g of G418/ml.
Monolayer cell cultures were trypsinized and fixed with cold calciumand magnesium-free phosphate-buffered solution (pH 7.2) containing 3.5% paraformaldehyde for 30 min on ice. Cells were washed three times in sterile PBS, and resuspended in 1 ml of sterile PBS for flow cytometry analysis. The cells were flow cytometrically analyzed (FACStar; Becton-Dickinson, San Jose, CA) with excitation at 488 nm from an argon laser operating at a constant power output of 200 W. The enhanced green fluorescence protein (EGFP) fluorescence signals were collected with a total accumulation of 10,000 cells/run.
Extraction of Nuclear Protein-Young (PD 25) and senescent 2BS cells (PD 62) were grown to 80% confluence before being washed three times with PBS and harvested by scraping with a rubber policeman. The cells were pelleted, washed twice with cold PBS, and resuspended in five packed cell volumes of 10 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, and 0.5 mM DTT (Buffer A). Following a 10 min incubation on ice, the cells were pelleted and resuspended in two packed cell volumes of buffer A. The cells were then lysed by Dounce homogenization and centrifuged at 25,000 ϫ g at 4°C for 20 min. The pellet was resuspended in 1 ml of 20 mM HEPES (pH 7.9), 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, and 0.5 mM phenylmethlylsulfonyl fluoride. The resuspended cells were stirred gently for 30 min at 4°C and centrifuged at 25,000 ϫ g for 30 min at 4°C. The supernatant was extensively dialyzed against 20 mM HEPES (pH 7.9), 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM DTT, and 0.5 mM PMSF. The protein concentration of the dialyzed material was determined by Lowry assay.
DNase I Footprinting Assay-DNase I footprinting reactions were performed as described in the protocol of SureTrack Footprinting Kit (Amersham Pharmacia Biotech). Briefly, young and senescent 2BS nuclear extracts were combined with binding buffer (20% glycerol, 20 mM Na-HEPES, pH 7.9, 100 mM KCl, 2 mM EDTA, 2 mM DTT, 4 mM Tris-HCl, pH 7.9), 1 g of poly(dI-dC), and 10,000 cpm of the endradiolabeled probe in a final volume of 50 l at room temperature for 30 min. Fresh dilutions of DNase I were made in 4 mM CaCl 2 , 10 mM MgCl 2 , and an appropriate volume was added to each reaction. After 1 min, 150 l of stop buffer (0.2 M NaCl, 20 mM EDTA, 1% SDS, and 250 mg/ml yeast RNA) was added, and reactions were subsequently extracted with phenol/chloroform, DNA-precipitated in ethanol, vacuumdried, and resuspended in formamide buffer. Samples were resolved on 6% sequencing gel. The gel was dried under vacuum and exposed to Eastman Kodak Co. X-Omat AR film for 48 -72 h. G ϩ A chemical sequence marker was electrophoresed with the sample to identify the size and location of the protected DNase I footprints.
Electrophoretic Mobility Shift Assay-Nuclear extracts from young and senescent 2BS cells were preincubated for 10 min at room temperature in a buffer containing 2 g of poly(dI-dC)⅐poly(dI-dC), 4% glycerol, 1.5 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, and 5 mM Tris-HCl, pH 7.5. Probe (50,000 cpm) was added and incubated at room temperature for 20 min. In competition experiments unlabeled oligonucleotides were added just prior to the addition of the probe. Reactions were analyzed on 4% polyacrylamide (30:1 acrylamide/bisacrylamide) gels in 0.5ϫ TBE. The gels were electrophoresed at 300 V at 4°C for ϳ3 h. After electrophoresis, the gel was dried and autoradiographed with an intensifier screen.
Southwestern Blot-120 g of young and senescent 2BS nuclear extracts were electrophoretically separated on a 7% SDS-polyacrylamide gel. Proteins from the gel were subsequently electroblotted onto nitrocellulose membranes. The blot was incubated in binding buffer (25 mM HEPES (pH 7.9), 3 mM MgCl 2 , 4 mM KCl, 1 mM dithiothreitol) at 4°C for 5 min. The filter was then blocked for 30 min in a 5% blotto solution. The blot was rinsed three times with binding buffer containing 0.25% blotto before the radiolabeled probe was added to the buffer. The blot was incubated with the probe for 16 h at 4°C, washed five times with binding buffer, and then exposed to Kodak X-Omat AR film for 24 -72 h.
Deletion Mutation Assay-Site-directed mutagenesis of the Ϫ870 bp p16
INK4a promoter was prepared by QuickChange TM site-directed mutagenesis methods. We designed a synthetic double-stranded oligonucleotide (5Ј-GGAAGGTTGGATCCCGGAGGAAGGAAACG-3Ј) to create a new BamHI site at position Ϫ482. Then two double-stranded oligonucleotide 5Ј-CTTTCCCTATGAGATCTAACACCCCGATTC-3Ј and 5Ј-GGCGGGGGCAGATCTCTTTTTAACAGAG-3Ј were used to create a new BglII site at position Ϫ522 and Ϫ451 of the promoter, respectively. BglII and BamHI produce compatible overhangs. When digested with these two endonucleases and ligated with T4-ligase, the fragment between BglII and BamHI was deleted. The nucleotide sequences of the deleted mutants were confirmed by a DNA sequencer, model 3700 (PerkinElmer Life Sciences). The wide type Ϫ870 bp p16
INK4a promoter and two deletion mutants 5Ј-MUT (Ϫ522 to Ϫ482 region deletion) and 3Ј-MUT (Ϫ482 to Ϫ451 region deletion) were inserted into XhoI and HindIII sites in pSEAP-Basic vector.
Transfection of the young (PD26) and senescent (PD62) 2BS cells were performed using FuGENE 6 (Roche Molecular Biochemicals). Transfected cells were harvested 48 h post-transfection, and SEAP activity was assayed using the Great EscAPe SEAP TM chemiluminescence detection kit (CLONTECH). SEAP light output was measured in a luminometer and normalized against the transfection pSV-␤-galactosidase control vector. Measurement of ␤-galactosidase was performed using a ␤-galactosidase enzyme assay system (Promega).
RESULTS

Definition of Functional Segments of p16
INK4a Promoter That Contribute to Overexpression of p16 in Senescent Fibroblasts by Functional Deletion Analysis-We used the EGFP reporter system to scan regulatory elements in the upstream region of p16
INK4a gene. On the base of self-inactivating retrovirus vector pSIR-EGFP, we constructed a series of plasmids in which various lengths of the p16
INK4a promoter were placed upstream of the EGFP. Transfecting the recombinant vectors into retrovirus packaging cells, we got virus supernatants. The young human fibroblasts were infected with virus. Then the infected cells were cultured to their finite life span. EGFP activity was measured by fluorescence-activated cell sorting. The data in Fig. 2 showed that very low expression of EGFP was observed in young and senescent cells infected by pSIR-EGFPϪ280, which contained Ϫ280 bp upstream from ATG of the p16 promoter. The activities of the Ϫ622, Ϫ870, Ϫ1400, Ϫ2070, and Ϫ3017 bp of the p16 promoter increased in senescent cells 5-7 times relative to that in young cells. Deletion from Ϫ3017 to Ϫ622 had little effect on promoter activity. A marked loss of promoter activity was observed when the region between Ϫ622 and Ϫ280 was excised (pSIR-EGFPϪ280). Together, these results indicated that the main transcription-regulatory elements contributing to overexpression of p16 in senescent cells were located in the region from Ϫ622 to Ϫ280 of the promoter.
Identification of Functional Elements in the p16
INK4a Promoter-We analyzed the DNA-protein interactions within the functionally important segment of the p16
INK4a promoter as a means to identify putative cis-acting elements that mediate promoter function. In vitro DNase I footprinting was performed with nuclear extracts from young and senescent 2BS cells and single end-labeled probe spanning Ϫ622 to Ϫ280. As seen in Fig. 3 , three footprints were detected in this region. Two regions (region A, from Ϫ507 to Ϫ493, and region C, extended from Ϫ466 to Ϫ450) could be combined with nuclear proteins extracted from both young and senescent 2BS cells. Region B that extended from Ϫ491 to Ϫ485 was mainly detected in the presence of extract from young 2BS cells. The positions and sequences of footprinted regions A, B, and C are shown in Fig.  4 . Regions A and B were separated only by one nucleotide. Region C was rich in GC sequence and contained the conventional consensus Sp1 binding site, 5Ј-GGGCGG-3Ј.
To examine the nuclear factors that bind to the footprinted region A, B, and C, we performed EMSA with young and senescent fibroblasts extracts. A 32 P-end-labeled segment from Ϫ622 to Ϫ374 of the p16 promoter was used for EMSA, and two double-stranded oligonucleotide probes (5Ј-oligo, whose sequence extended from Ϫ525 to Ϫ481 covering the footprinted region A and B, and 3Ј-oligo, whose sequence extended from Ϫ480 to Ϫ447 covering the footprinted region C; Fig. 4) were used for competition. Six retarded bands were detected as shown in Fig. 5 . Band e, which was completely competed by 5Ј-oligo, could only be detected in the presence of extract from young 2BS cells. Bands a, b, c, and f could be competed by 3Ј-oligo probe. Among them, bands b and c could only be detected in the presence of extract from senescent 2BS cells.
We next studied the molecular weight of DNA-binding proteins that could combine with the region from Ϫ622 to Ϫ280 of the p16 promoter with Southwestern blotting. As showed in Fig. 6 , a 24-kDa binding protein was observed only in young cells, and 15.5-kDa binding protein could be detected in both kinds of cells.
In order to investigate the contribution of the protected regions acquired from the DNase I footprinting assay toward the promoter activity, we deleted the region from Ϫ522 to Ϫ482 (named 5Ј-MUT) and the region Ϫ482 to Ϫ451 (called 3Ј-MUT) from Ϫ870 bp of the p16 promoter, respectively. After inserting these two kinds of mutated promoters and the wild type Ϫ870 bp p16 promoter into the multiple clone sites of pSEAP-Basic vector, we generated three mutational reporter gene expression vectors, pSEAPϪ870, pSEAP-5Ј-MUT, and pSEAP-3Ј-MUT. Recombinant vectors were transfected into young and senescent 2BS cells. pSEAP-5Ј-MUT with the Ϫ522 to Ϫ482 deletion showed that promoter activity increased by 72% in young cells, while no significant change occurred in senescent cells. Deletion of the region from Ϫ482 to Ϫ451 showed a 91.4% loss of activity of p16
INK4a promoter in senescent cells, and the promoter activity decreased by 41.2% in young cells comparably (Figs. 7 and 8 ).
DISCUSSION
The vector pSIR used for 5Ј-deletion study is a self-inactivating retrovirus vector (19) . It contains a 176-bp deletion in the 3Ј-long terminal repeat that removes the enhancer sequence. Following reverse transcription, the 3Ј-long terminal repeat is copied and replaces 5Ј-long terminal repeat resulting in inactivation of the 5Ј-long terminal repeat promoter. It can be used for transcription regulatory research. The results of the 5Ј-deletion assay indicated that the activities of different length (Ϫ622 to Ϫ3017 bp) of the p16
INK4a promoter were enhanced by 5-7-fold during the fibroblast aging process, which was much lower than the increment level of p16
INK4a mRNA and protein
FIG. 2. Deletion analysis of the human p16
INK4a promoter activities in young and senescent 2BS cells. The left panel is a schematic representation of the constructs used in transcription activity assays. The right panel displays the relative promoter activity of the different constructs. The promoter relative activity was calculated relative to the 870-bp promoter activity in senescent cells, which was arbitrarily set at 100%.
in senescent cells. In many cultured cell lines, such as fibroblasts, keratinocytes, and urothelial cells, p16
INK4a accumulates with increasing numbers of population doublings (2, (5) (6) (7) (8) . Interestingly, the levels of p16
INK4a continue to rise after the cells have effectively ceased to divide (2) . Since p16 RNA is extremely stable (3), many researchers hypothesize that accumulation of p16
INK4a mRNA and proteins with each PD may lead to overexpression of this gene in senescent cells (3, 20) . However, the significant elevation of p16
INK4a begins from the late stage of senescence, but not from early passage, gradually. There are no significant changes in p16 INK4a RNA stability between early passage and late passage fibroblast cells (3). So we hypothesized that there are some negative regulatory mechanisms in young fibroblasts that inhibit the transcription of p16
INK4a by negative feedback to prevent the accumulation of p16
INK4a in young cells. In senescent cells, the negative regulatory mechanisms are turned off, which will lead to elevation of p16 promoter activity. On the other hand, the loss of negative regulation will initiate the accumulation of p16
INK4a . Therefore, we suppose that the loss of negative regulatory mechanisms plays a primary role in overexpression of p16 INK4a in senescent cells.
We located the main regulatory elements contributing to the overexpression of p16
INK4a in the region of the promoter from Ϫ622 to Ϫ280 through 5Ј-deletion assays. Then we studied the DNA-protein interactions with this fragment in vitro. The result of DNase I footprinting showed that the fragment spanning Ϫ491 to Ϫ485 relative to the ATG was specifically protected from DNase I digestion by nuclear extracts from young 2BS cells. As mentioned above, the activity of the Ϫ622 bp promoter increased by 5-fold in the fibroblast aging process. We postulate that the region (Ϫ491 to Ϫ485) may be a silencer. In order to confirm this theory, we performed EMSA and sitedirected deletion assays. The fragment (Ϫ622 to Ϫ374) was end-labeled and incubated with nuclear extracts from young and senescent cells, respectively. The formation of DNA-protein complexes that could be competed by a 100-fold molar excess of the synthetic 5Ј-oligo oligonucleotides completely was only detected in young cells (Fig. 5, band e) . The fragment (Ϫ522 to Ϫ482) was deleted from Ϫ870 bp of the p16 promoter. The deletion resulted in a drastic increase in promoter activity to about 170.2% compared with the wild type promoter (set arbitrarily at 100%) in young cells and no significant change in senescent cells. The results demonstrated that the region (Ϫ491 to Ϫ485) was a negative regulatory element, and it mediated transcriptional inhibition of p16
INK4a by interacting with a protein factor highly expressed in young cells. This functional element did not contain consensus sequence of cisacting transcription factors that have been reported. It was a novel silencer, ITSE. The sequence of ITSE is 5Ј-GAAGGTT-3Ј. A transcription inhibition factor that was highly expressed in young cells may inhibit the expression of p16 by interacting with ITSE.
Up to now, it is known that the Id family of helix-loop-helix proteins can inhibit the transcription of p16
INK4a . The loss of Id function has been linked to replicative senescence (21) . The mouse embryo fibroblasts derived from Id1-deficient mice express high levels of p16
INK4a (22) . Id1 interacts with Ets2 and blocks its transcriptional activation effect on p16
INK4a (23) . Unlike basic helix-loop-helix proteins, Ids lack a DNA-binding activity due to the absence of a basic domain (24) . The protein binding to ITSE did not belong to the Id family of transcription factors. We performed Southwestern blot to detect the molecular weight of the proteins that can bind to the fragment (Ϫ622 to Ϫ280) of the p16
INK4a promoter. A 24-kDa protein could only be detected in young 2BS cells. We postulated that this protein was the transcription inhibition factor binding to and acting through ITSE, but it needs further confirmation.
The GC-abundant region C (Ϫ466 to Ϫ450; Fig. 3 ) was another footprinted region. It could be protected by nuclear protein extracted from both young and senescent fibroblasts. The electrophoretic mobility shift assays with fragment Ϫ622 to Ϫ374 as the labeled probe and a 100-fold molar excess of the 3Ј-oligo unlabeled oligonucleotide as competitor indicated that the gel mobility-retarded DNA-protein complexes a, b, c, and f were competed by the 3Ј-oligo oligonucleotide. Moreover, com- The sequence of region C was 5Ј-ACGGGGCGGGGGCGGA-3Ј. It contained two conventional consensus Sp family protein (25) binding sites, 5Ј-GGGCGG-3Ј. This GC-box element is an important and widely distributed promoter element (26) . It is required for the appropriate expression of many ubiquitous, tissue-specific and viral genes. In addition, it occurs frequently in the regulatory region of genes that are under a specific mode of control such as cell cycle regulation, tumor genesis, hormonal activation, and developmental and senescent patterning. The transcription factors that can bind to and act though the GC-boxes are the Sp family of proteins (27) . This family consists of four proteins designated Sp1, Sp2, Sp3, and Sp4. All four human Sp family members have similar structures. The DNA binding domain close to the C terminus contains three zinc fingers. The zinc finger structure is highly conserved in Sp1, Sp3, and Sp4 but not in Sp2. Consistently, Sp1, Sp3, and Sp4 recognize the classical GC-box element with identical affinity (28, 29) , while Sp2 does not bind to the GC-box but to a GT-rich element (30) . Both Sp1 and Sp4 are known to be strong transcriptional activators. Sp4 expression appears to be restricted to a few tissues. High levels of Sp4 are predominantly found in the brain (31) . The transcriptional role of Sp3 is complicated. In some experiments, Sp3 was shown to act as a transcriptional activator similar to Sp1 (32, 33) . In other experiments, Sp3 acted as a transcriptional repressor of Sp1-mediated activation (34, 35) . The Sp family of proteins are involved in regulating the activities of senescence-regulated genes such as p21 WAF1 (36) and Werner helicase genes (37). Fukami-Kobayashi et al. (38) investigated the binding of nuclear protein factors to the cyclin D1 gene promoter domain in young and senescent nor- FIG. 5 . Electrophoretic mobility shift assay of the region from ؊622 to ؊374 of the p16 promoter. EMSA was performed using nuclear extracts obtained from either young or senescent 2BS cells. The fragment was radiolabeled and incubated with 4 g of nuclear protein or 4 g of BSA for control (lane 1). Competition was performed in the presence of a 100-fold molar excess of the synthetic nonradioactive oligonucleotides according to the footprinting result. 5Ј-oligonucleotides were the sequence of Ϫ525 to Ϫ481 of the p16 promoter (lanes 4 and 5) . 3Ј-Oligonucleotides were the sequence of Ϫ480 to Ϫ447 of the p16 promoter (lanes 6 and 7) . a-f, six shifted binding bands.
FIG. 6.
Southwestern blotting of the fragment from ؊622 to ؊280 of the p16 promoter. End-labeled probe was incubated with nuclear extracts of young and senescent 2BS cells, which were separated by SDS-PAGE and transferred to nitrocellulose membrane. A 24-kDa binding protein was observed only in young cells, and a 15.5-kDa binding protein could be detected in both cells.
FIG. 7. SEAP activity in young 2BS cells.
The pSEAP-5Ј-MUT construct with a Ϫ522 to Ϫ482 deletion showed a 72% increase of promoter activity. The pSEAP-3Ј-MUT construct with a Ϫ482 to Ϫ451 deletion showed a 41.2% loss of activity. The mean activity and S.D. values were relative to wide type promoter activity, which was arbitrarily set at 100% (*, p Ͻ 0.05; **, p Ͻ 0.01).
FIG. 8. SEAP activity in senescent 2BS cells.
The pSEAP-5Ј-MUT construct with a Ϫ522 to Ϫ482 deletion showed no significant change of promoter activity. The pSEAP-3Ј-MUT construct with a Ϫ482 to Ϫ451 deletion showed a 91.2% loss of activity. The mean activity and S.D. values were relative to wide type promoter activity, which was arbitrarily set at 100% (**, p Ͻ 0.01).
mal human fibroblasts to clarify the molecular mechanisms of cyclin D1 expression during in vitro cellular aging. They found that the binding of Sp1 to its promoter element occurred only in senescent cells, which may promote the increase of cyclin D1 expression during cellular aging. In humans, serum transferrin levels decrease during the aging process. A decrease in Sp1-like binding activity was shown to cause decreased transcription of the human transferrin gene (5) . In our study, we found when the GC-box element located in Ϫ466 to Ϫ450 was deleted, the decrease of p16 promoter activity in senescent cells was much higher than in young cells, which suggested that the GC-boxbinding proteins contributed to the increase of p16
INK4a expression in senescent cells.
